Table 2.
Drug | Target | Reference | |
---|---|---|---|
Thrombin antagonists | Vorapaxar (SCH530348) | PAR1 antagonist | [81, 82] |
Atopaxar (E5555) | PAR1 antagonist | [81, 82] | |
Hirudin | Cleave fibrinogen and PAR-1 | [74, 83–85] | |
| |||
Herbal medicines | Curcuminoids | Anti-inflammatory | [88, 89] |
Chondrocytes protection | [88] | ||
β-Ecdysterone (Ecd) | Bax and p53 reduction | [90] | |
Increase Bcl-xL expression, | [90] | ||
Inhibited NF-κB phosphorylation, | [90] | ||
IκBα degradation, MMP-3, | [90] | ||
MMP-9, and COX-2 expression | [90] | ||
Ceiba pentandra (Malvaceae/Bombacoideae) | Coagulation intrinsic pathway | [91] | |
Prolong clotting time | [91] | ||
Quassia africana (Simaroubaceae/C. pentandra) | Coagulation intrinsic pathway | [91] | |
Prolong clotting time | [91] |